GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hammadi Holding (SAU:4007) » Definitions » Valuation Rank

Hammadi Holding (SAU:4007) Valuation Rank


View and export this data going back to 2014. Start your Free Trial

What is Hammadi Holding Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Hammadi Holding Valuation Rank Related Terms

Thank you for viewing the detailed overview of Hammadi Holding's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Hammadi Holding (SAU:4007) Business Description

Traded in Other Exchanges
N/A
Address
Al-Olaya, P.O. Box 10112, Riyadh, SAU, 11443
Hammadi Holding is engaged in the activities of wholesale and retail trading of medical equipment, pharmaceutical and cosmetic products, establishing, managing, and operating hospitals and medical centers, wholesale and retail trading of food and beverages, purchasing and rentals of lands for construction buildings and investing, initiating commercial centers, operating and maintaining them. The operating segment of the company are Medical Services and Pharmaceuticals Products segment. It generates maximum revenue from the Medical Services segment. The Medical Services segment includes fees for inpatient and outpatient services.